Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 21
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
18 to5
Pharmaceutical / Industry
1839IL/0143
NCT00234429
Last Modified:
5/14/2007
 
First Published:
12/1/1996
2.
Phase III Randomized Study of Leucovorin and Fluorouracil Versus Continuous-Infusion Fluorouracil Versus ICI D1694 as Palliative Therapy for Advanced Colorectal Cancer, With a Second Randomization in Stable and Responding Patients for Continued Chemotherapy Versus Observation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
Not specified
MRC-CR06
EU-96049, NCT00002893
Last Modified:
8/14/2007
 
First Published:
8/1/1998
3.
Phase III Randomized Study of Raltitrexed Versus Standard Leucovorin Calcium-Modulated Bolus Fluorouracil for Stage III Colon Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
EORTC-40962
PETACC-1
Last Modified:
12/20/2007
 
First Published:
3/1/2000
4.
Phase III Randomized Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
Over 18
Other
EORTC-08983
NCT00004920
Last Modified:
7/18/2006
5.
Phase II Study of ICI D1694, a Thymidylate Synthase Inhibitor, for Advanced Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
E-6293
E6293
Last Modified:
6/1/1999
6.
Phase II Study of ICI D1694 for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 06/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
adult
NCI
SWOG-9519
Last Modified:
8/1/1999
7.
Phase II Study of ICI D1694 (a Thymidylate Synthase Inhibitor) for Advanced Hormone-Refractory Prostate Cancer (Summary Last Modified 08/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
over 18
NCI
NCCTG-935251
NCCTG-93-52-51
Last Modified:
3/1/1998
 
First Published:
12/1/1997
8.
Phase II Study of Raltitrexed (Tomudex) in Adult Recurrent Metastatic Soft Tissue Sarcomas (Summary Last Modified 03/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
15-75
Pharmaceutical / Industry
EORTC-62951
Last Modified:
2/6/2007
 
First Published:
2/1/2000
9.
Phase II Study of Raltitrexed in Patients With Inoperable Malignant Mesothelioma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
Over 18
EORTC-08992
NCT00004254
Last Modified:
7/1/1993
10.
Phase II Study of ICI D1694, a Thymidylate Synthase Inhibitor, in Patients with Pancreatic or Gastric Adenocarcinoma (Summary Last Modified 07/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
MSKCC-93019
NCI-V93-0246
Select All on One Page
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute